In the present study, membranous PODXL expression was denoted in 49.5 % of primary PB-type carcinomas, which is somewhat lower than in the previous study by Dallas et al., including tumours from 105 cases assembled in TMAs, wherein membranous PODXL expression was found in 69 % of the cases [22]. This evidence concerns the gene PODXL and carcinoma.